Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients

Background: Tuberculosis drug-induced liver injury (TB-DILI) is a common and potentially severe adverse drug reaction leading to treatment interruption and treatment failure. The real-world preventive effectiveness of hepatoprotective agents for DILI is not well described. The aim of the study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qin, Hu, Airong, Ma, Aixia, Jiang, Feng, Xiao, Yue, Chen, Yanfei, Huang, Ruijian, Yang, Tianchi, Zhou, Jifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065346/
https://www.ncbi.nlm.nih.gov/pubmed/35517815
http://dx.doi.org/10.3389/fphar.2022.813682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065346/
https://www.ncbi.nlm.nih.gov/pubmed/35517815
http://dx.doi.org/10.3389/fphar.2022.813682

Ejemplares similares